FDA's OTAT morphs into the Office of Therapeutic Products as new funds await
Ready for a makeover with new PDUFA VII funds on deck, the FDA’s Center for Biologics Evaluation and Research said Tuesday that they will retitle …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
